Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
News|Videos|October 17, 2016
How Pharmacists Can Improve Access to Expensive Specialty Drugs
Author(s)Lauren Santye, Assistant Editor
Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses how to address the challenge of access to high cost specialty medications.
Advertisement
Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses how to address the challenge of access to high cost specialty medications.
Advertisement
Related to this article
Doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd (Voceryq) targets HPV-6 and HPV-11 to reduce the surgical burden for adults with recurrent respiratory papillomatosis, a rare airway disease.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Amivantamab Becomes First FDA-Approved Therapy in 10 Years for Pretreated Recurrent or Metastatic HNSCC
2
AHA 2026: Insights on Oral PCSK9, Survodutide, and HF Care Come to Chicago
3
Understanding Kratom: Pharmacology, Safety, and Regulation
4
CVS Health to Split Into 2 Public Companies, Separating Retail and Specialty Pharmacy
5